Cargando…

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials

BACKGROUND: For medical conditions with numerous interventions worthy of investigation, there are many advantages of a multi-arm multi-stage (MAMS) platform trial approach. However, there is currently limited knowledge on uptake of the MAMS design, especially in the late-phase setting. We sought to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noor, Nurulamin M, Love, Sharon B, Isaacs, Talia, Kaplan, Richard, Parmar, Mahesh K B, Sydes, Matthew R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915371/ https://www.ncbi.nlm.nih.gov/pubmed/35273052 http://dx.doi.org/10.1136/bmjopen-2021-055615

Ejemplares similares

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
por: Noor, Nurulamin M., et al.
Publicado: (2020)

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
por: Gilson, C., et al.
Publicado: (2017)

The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2011)

Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer
por: Zeissler, Marie-Louise, et al.
Publicado: (2020)

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2012)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
por: Bratton, Daniel J, et al.
Publicado: (2013)

Mind the gap? The platform trial as a working environment
por: Morrell, Liz, et al.
Publicado: (2019)

Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial
por: Choodari-Oskooei, Babak, et al.
Publicado: (2023)

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016)

Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
por: Lensen, Sarah, et al.
Publicado: (2020)

Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome
por: Phillips, Patrick, et al.
Publicado: (2013)

How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design – a reanalysis of 4 trials
por: Barthel, FM-S, et al.
Publicado: (2009)

The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness
por: Hessl, David, et al.
Publicado: (2022)

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease
por: Wong, Charis, et al.
Publicado: (2022)

Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently
por: White, Ian R, et al.
Publicado: (2022)

A multi-arm multi-stage design for binary outcomes and application to tuberculosis
por: Bratton, Daniel, et al.
Publicado: (2013)

Systematic review of available software for multi-arm multi-stage and platform clinical trial design
por: Meyer, Elias Laurin, et al.
Publicado: (2021)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis
por: Li, Vivien, et al.
Publicado: (2022)

Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)

The design of a multi-arm multi-stage (MAMS) phase III randomised controlled trial comparing alternative regimens for escalating (COMPARE) treatment of intermediate and high-risk oropharyngeal cancer with reflections on the complications of introducing a new experimental ARM
por: Gaunt, Piers, et al.
Publicado: (2015)

Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
por: Blenkinsop, Alexandra, et al.
Publicado: (2019)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013)

Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART)
por: Parker, Richard A., et al.
Publicado: (2023)

A framework for the design and analysis of phase III randomised trials in uncommon diseases
por: Parmar, Mahesh, et al.
Publicado: (2015)

An order restricted multi‐arm multi‐stage clinical trial design
por: Serra, Alessandra, et al.
Publicado: (2022)

Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer
por: Mochiki, E, et al.
Publicado: (2012)

How do you design randomised trials for smaller populations? A framework
por: Parmar, Mahesh K. B., et al.
Publicado: (2016)

Embracing model-based designs for dose-finding trials
por: Love, Sharon B, et al.
Publicado: (2017)

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
por: Murray, Daniel D., et al.
Publicado: (2021)

I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations
por: Files, Daniel Clark, et al.
Publicado: (2022)

Innovations to improve the efficiency of phase II IBD clinical trials
por: Noor, Nurulamin M., et al.
Publicado: (2023)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

A multi-stage drop-the-losers design for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2016)

National survey of feasibility of NIV trials for management of children with bronchiolitis
por: Rosala-Hallas, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_70mnqcg4cc674rfmqgvd4hk8bt